Jin Ding

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
60 papers · 5,785 citations · H-index 39

PAPERS

Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma.
202271 citationsauthor #10
SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA/Hippo signaling
202118 citationsauthor #10
Abstract P236: Targeting AXL/PDK1 signaling axis activates immunogenic cell death in liver cancer
20210 citationsauthor #5
Glycogen accumulation and phase separation drives liver tumor initiation.
2021250 citationsauthor #21
Comprehensive analysis of miRNA-gene regulatory network with clinical significance in human cancers
20208 citationsauthor #4
Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma
202070 citationsauthor #7
High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma
202018 citationsauthor #14
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance
2020102 citationsauthor #17
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
201992 citationsauthor #7
The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production
2019149 citationsauthor #6
Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma
2019112 citationsauthor #5
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
2019109 citationsauthor #17
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
201944 citationsauthor #11
Liver Cancer Stem Cells
20181 citationsauthor #1
Abstract 901: Antibody-mediated blockade of annexin A3 (ANXA3) synergistically enhances the efficacy of sorafenib and regorafenib for hepatocellular carcinoma
20180 citationsauthor #7
PARP10 suppresses tumor metastasis through regulation of Aurora A activity
201849 citationsauthor #11
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
201874 citationsauthor #9
Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors
201867 citationsauthor #16
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib.
2018105 citationsauthor #10
Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis
201836 citationsauthor #6
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
201780 citationsauthor #7
Abstract 3146: Targeting ANXA3 in combination with sorafenib for the treatment of hepatocellular carcinoma
20170 citationsauthor #4
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
2017196 citationsauthor #18
Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance
2017105 citationsauthor #18
FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice
201740 citationsauthor #8
FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice
20170 citationsauthor #8
Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation.
2017157 citationsauthor #10
Shp2 promotes liver cancer stem cell expansion by augmenting β‐catenin signaling and predicts chemotherapeutic response of patients
2017134 citationsauthor #18
Characteristics of liver cancer stem cells and clinical correlations.
201683 citationsauthor #3
Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
2016194 citationsauthor #7
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.
2016968 citationsauthor #2
Inhibition of SIRPα in dendritic cells potentiates potent antitumor immunity
201639 citationsauthor #10
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
2016199 citationsauthor #10
Long Non-coding RNA DILC Represses Self-renewal of Liver Cancer Stem Cells via Inhibiting Autocrine IL-6 / STAT 3 Axis
20164 citationsauthor #11
inFRank: a ranking-based identification of influential genes in biological networks
20166 citationsauthor #7
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
2016280 citationsauthor #11
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
2015134 citationsauthor #16
An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells
201572 citationsauthor #9
ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling
201513 citationsauthor #1
ψ-Bufarenogin, a lead compound of anti-cancer drug
20154 citationsauthor #1
A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
201562 citationsauthor #9
Hepatocyte Nuclear Factor 4 alpha-Nuclear Factor-kappa B Feedback Circuit Modulates Liver Cancer Progression
201429 citationsauthor #2
Corrigendum to “Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells” [Cancer Letters 336/1 (2013) 204–212]
20140 citationsauthor #7
Hepatocyte nuclear factor 4α‐nuclear factor‐κB feedback circuit modulates liver cancer progression
201493 citationsauthor #2
Multiple interactive factors in hepatocarcinogenesis.
201491 citationsauthor #1
Cyclin G1 Expands Liver Tumor-Initiating Cells by Sox2 Induction via Akt/mTOR Signaling
201343 citationsauthor #13
Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells.
201329 citationsauthor #7
Cyclin G1–mediated epithelial‐mesenchymal transition via phosphoinositide 3‐kinase/Akt signaling facilitates liver cancer progression
2012105 citationsauthor #2
Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development
2012200 citationsauthor #2
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.
2011333 citationsauthor #3
Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/HIF-dependent signaling pathway.
201144 citationsauthor #5
Gankyrin‐mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
201155 citationsauthor #2
atocyte Nuclear Factor 4α Suppresses the Development
20101 citationsauthor #1
Molecular Signaling in Hepatocellular Carcinoma
20108 citationsauthor #2
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
2010214 citationsauthor #2
Suppression of cyclin D1 by hypoxia-inducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells.
201090 citationsauthor #2
Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells
200949 citationsauthor #1
Cyclin D1 Induction by Benzo[a]pyrene-7,8-diol-9,10-epoxide via the Phosphatidylinositol 3-Kinase/Akt/MAPK- and p70s6k-dependent Pathway Promotes Cell Transformation and Tumorigenesis*
200925 citationsauthor #1
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.
2009231 citationsauthor #9
From cell signaling to cancer therapy
200713 citationsauthor #1

TIMELINE

2007 13 citations

2009 305 citations

2010 313 citations

2011 432 citations

2012 305 citations

2013 72 citations

2014 213 citations

2015 285 citations

2016 1,773 citations

2017 712 citations

2018 332 citations

2019 506 citations

2020 198 citations

2021 268 citations

2022 71 citations

COAUTHOR MAP

CONCEPT FOOTPRINT